Prevalence of HIV and hepatitis C virus infections and related behavioral determinants among injecting drug users of drop-in centers in Iran

Iranian Red Crescent Medical Journal

Volumn 11, Issue 3, 2009, Pages 325-329

  Mirahmadizadeh, Ali Reza ^a   Majdzadeh, R ^a   Mohammad, K ^a   Forouzanfar, M H ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DICs; HCV; High risk behaviors; HIV; IDUs; Iran; Prevalence

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; DRUG ABUSE PATTERN; FEMALE; HEPATITIS C; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INTERVIEW; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; RISK REDUCTION; SEXUAL BEHAVIOR;

EID: 67749110279     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Razzaghi EM, Movaghar AR, Green TC, Khoshnood K. Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran. Harm Reduct J 2006;3:12. [16545137] [doi:10.1186/1477-7517-3-12]
2. Haverkos HW. Infectious diseases and drug abuse. Prevention and treatment in the drug abuse treatment system. J Subst Abuse Treat 1991;8:269-75. [1787552] [doi:10.1016/0740-5472(91)90050-K]
3. Iranian Ministry of Health and Medical Education: Statistics on HIV/AIDS in Iran. 2003. (In Persian)
4. Salazar C, Hamidreza S. Uniting the World against AIDS. Iran (Islamic Republic of) UNAIDS: Joint United Nations Programme on HIV/AIDS, 2006.
5. Vazirian M. Review of drug demand reduction programs in Iran. Advices for development and strategic planning, Social Welfare Quarterly 2003;9:145-201 (in Persian).
6. Single E. Defining harm reduction. Drug Alcohol Rev 1995; 14:287-90. [16203323] [doi:10.1080/09595239500185371]
7. Thomas G. Harm Reduction Policies and Programs for Persons Involved in the Criminal Justice System Ottawa: Canadian Centre on Substance Abuse, 2005.
8. Razzaghi EM, Rahimi Movaghar A, Hosseini M, Madani S, Chatterjee A. Rapid Situation Assessment of Drug Abuse in Iran. Iranian Welfare Organization and UNDCP, 1999.
9. Iran UNGASS HIV report of 2008. National secretariat for monitoring of HIV/AIDS. data.unaids.org/pub/Report2008/ iran_2008_country∥ogress_report⊥rsian_xx.pdf. (20 Jan 2009)
10. Day C, Nassirimanesh B, Shakeshaft A, Dolan K. Patterns of drug use among a sample of drug users and injecting drug users attending a General Practice in Iran. Harm Reduct J 2006;3:2. [16433914] [doi:10.1186/1477-7517-3-2]
11. Vazirian M, Nassirimanesh B, Zamani S, Ono-Kihara M, Kihara M, Ravari SM, Gouya MM. Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study. Harm Reduct J 2005;2:19. [16212 655] [doi:10.1186/1477-7517-2-19]
12. Joint UNAIDS program on HIV/AIDS and WHO AIDS Epidemic Update December 2002. UNAIDS: Geneva, Switzerland, 2002.
13. UNAIDS Factsheet 2002. The Middle East and North Africa, UNAIDS, Geneva, Switzerland, 2002.
14. Afshar P. Personal Communication, September 2003. (Director General of Health, Iran Prisons Organization), 2003.
15. Rowhani Rahbar A, Rooholamini S, Khoshnood K. Prevalence of HIV infection and other blood-borne infections in incarcerated and nonincarcerated injection drug users (IDUs) in Mashhad, Iran. Drug Policy Int J 2004;15:151-55. [doi: 10.1016 /j.drugpo.2003.07.001]
16. Mohtasham Amiri Z, Rezvani M, Jafari Shakib R, Jafari Shakib A. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilance province. East Mediterr Health J 2007; 13:250-6. [17684845]
17. Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol 2005;11:4085-9. [15996035]
18. Alavi SM, Etemadi A. HIV/HBV, HIV/HCV and HIV/HTLV-1 co infection among injecting drug user patients hospitalized at the infectious disease ward of a training hospital in Iran. Pak J Med Sci 2007; 23:510-13.
19. United Nations Office on Drugs and Crime. Substance abuse treatment and care for women: Case studies and lessons learned, 2004.
20. Aceijas C, Friedman SR, Cooper HL, Wiessing L, Stimson GV, Hickman M. Estimates of injecting drug users at the national and local level in developing and transitional countries and gender and age distribution. Sex Transm Infect 2006; 82:iii10-17. [16735287] [doi:10.1136/sti.2005.019471]
21. Zhang LL, et al. An investigation into HIV infection and related behavioral factors among drug users in correctional centers. J Prev Med Information 1999; 15:138-139.
22. Sarkar S, Panda S, Sarkar K, Hangzo CZ, Bijaya L, Singh NY, Das N, Agarwal A, Chatterjee A, Deb BC, et al. A cross-sectional study on factors including HIV testing and counseling determining unsafe injecting practices among injecting drug users of Manipur. Indian J Public Health 1995;39:86-92. [8690497]
23. Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007; 18:352-8. [17 854722] [doi:10.1016/j.drugpo.2007.04.004]
24. Report on the global AIDS epidemic2008. (www.unaids.org)
25. Macalino GE, Celentano DD, Latkin C, Strathdee SA, Vlahov D. Risk behaviors by audio computerassisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev 2002;14:367-78. [12413183] [doi:10.1521/ aeap.14.6.367.24075]
26. Adelekan M, Green A, Dasgupta N, Tallack F, Stimson GV, Wells B. Reliability and validity of the Opiate Treatment Index among opioid users in the United Kingdom. Drug Alcohol Rev 1996; 15:261-70. [16203381] [doi:10.1080/09595239600186001]
27. Dowling-Guyer S, Johnson ME, Fisher DG, et al. Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment 1994; 1:383-92.
28. Weatherby N, Needle R, Cesari H, et al. Validity of self-reported drug use among injection drug users recruited through street outreach. Evaluation and Program Planning 1994;17:347-355.